A NON-INTERVENTIONAL OBSERVATIONAL STUDY ASSESSING SAFETY OF DEFERASIROX IN PATIENTS WITH HEMOGLOBINOPATHIES AND TRANSFUSIONAL IRON OVERLOAD: RESULTS FROM THE "ENERGY" STUDY

被引:0
|
作者
Voskaridou, E. [1 ]
Dimopoulou, M. [1 ]
Drosou, M. [2 ]
Vini, D. [2 ]
Ladis, V. [3 ]
Kattamis, A. [3 ]
Economou, M. [4 ]
Vlachaki, E. [5 ]
Symeonidis, A. [6 ]
Kouraklis, A. [6 ]
Dimitriadou, E. [7 ]
Kapsali, E. [8 ]
Chatziliami, A. [9 ]
Fragodimitri, C. [9 ]
Lafioniatis, S. [10 ]
Karavas, A. [11 ]
Klironomos, E. [12 ]
Aggelaki, M. [13 ]
Calpaka, A. [13 ]
Kontogianni, K. [14 ]
Michos, A. [15 ]
Papageorgiou, U. [16 ]
Lafiatis, I. [17 ]
Adamopoulos, I. [18 ]
机构
[1] Laiko Univ, Gen Hosp Athens, Thalassemia Ctr, Athens, Greece
[2] Gen Hosp Agios Panteleimon Nikea, Piraeus, Greece
[3] Univ Athens, Agia Sofia Childrens Hosp, Thalassemia Unit, Dept Pediat 1, Athens, Greece
[4] Aristotle Univ Thessaloniki, Thalassaemia Unit, Paediat Dept 1, Hippokrat Gen Hosp Thessaloniki, GR-54006 Thessaloniki, Greece
[5] Hippokrateon Hosp, Adult Thalassemia Unit, Dept Internal Med 2, Thessaloniki, Greece
[6] Univ Patras, Sch Med, Dept Internal Med, Div Hematol, GR-26110 Patras, Greece
[7] Gen Hosp Trikala, Trikala, Greece
[8] Ioannina Univ Hosp, Thalassemia Unit, Dept Clin Hematol, Ioannina, Greece
[9] Childrens Hosp Athens Agia Sofia, Athens, Greece
[10] Gen Hosp Achilopouleio Volos, Volos, Greece
[11] Drakopouleio Blood Ctr Athens, Athens, Greece
[12] Venizel Gen Hosp Heraklion, Thalassaemia Unit, Iraklion, Greece
[13] Gen Hosp Agios Pavlos Thessaloniki, Thessaloniki, Greece
[14] Univ Hosp Larissa, Larisa, Greece
[15] Gen Hosp Corfu, Thalassaemia Unit, Corfu, Greece
[16] Karamandaneio Childrens Hosp, Patras, Greece
[17] Gen Hosp Vostanio Mytilini, Mitilini, Greece
[18] Gen Hosp Kalamata, Kalamata, Greece
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
E1473
引用
收藏
页码:590 / 591
页数:2
相关论文
共 50 条
  • [21] Assessment of non-transferrin bound iron in patients with myelodisplastic syndrome and transfusional iron overload treated with deferasirox
    Del Orbe, R.
    Arrizabalaga, B.
    Zamora, M.
    Etxeguren, I.
    Olivares, M.
    Aragues, P.
    Erkiaga, S.
    Cantelli, B.
    Urresola, A.
    Collado, R.
    LEUKEMIA RESEARCH, 2013, 37 : S107 - S107
  • [22] Concomitant Medications and Gastrointestinal Events in Thalassemia and MDS Patients Receiving Deferasirox for Transfusional Iron Overload: Data From the EPIC Study
    Cappellini, M. Domenica
    El-Beshlawy, Amal
    Porter, John B.
    Kattamis, Antonis
    Taylor, Kerry
    Rose, Christian
    Louw, Vernon J.
    El-Ali, Ali
    Martin, Nicolas
    Gattermann, Norbert
    BLOOD, 2012, 120 (21)
  • [23] The safety of finasteride used in benign prostatic hypertrophy: A non-interventional observational cohort study in 14772 patients
    Wilton, L
    Pearce, G
    Edet, E
    Freemantle, S
    Stephens, MDB
    Mann, RD
    BRITISH JOURNAL OF UROLOGY, 1996, 78 (03): : 379 - 384
  • [24] Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England
    Osborne, Vicki
    Davies, Miranda
    Layton, Deborah
    Shakir, Saad A. W.
    DRUG SAFETY, 2018, 41 (03) : 267 - 275
  • [25] Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England
    Vicki Osborne
    Miranda Davies
    Deborah Layton
    Saad A. W. Shakir
    Drug Safety, 2018, 41 : 267 - 275
  • [26] Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study
    Dartigeas, Caroline
    Quinquenel, Anne
    Ysebaert, Loic
    Dilhuydy, Marie-Sarah
    Anglaret, Bruno
    Slama, Borhane
    Le Du, Katell
    Tardy, Stephanie
    Tchernonog, Emmanuelle
    Orfeuvre, Hubert
    Voillat, Laurent
    Guidez, Stephanie
    Malfuson, Jean-Valere
    Dupuis, Sandrine
    Deslandes, Marine
    Feugier, Pierre
    Leblond, Veronique
    ANNALS OF HEMATOLOGY, 2024, 104 (2) : 1079 - 1093
  • [27] Long-term safety and efficacy of deferasirox in young pediatric patients with transfusional hemosiderosis: Results from a 5-year observational study (ENTRUST)
    Vichinsky, Elliott
    El-Beshlawy, Amal
    Al Zoebie, Azzam
    Kamdem, Annie
    Koussa, Suzanne
    Chotsampancharoen, Thirachit
    Bruederle, Andreas
    Gilotti, Geralyn
    Han, Jackie
    Elalfy, Mohsen
    PEDIATRIC BLOOD & CANCER, 2017, 64 (09)
  • [28] Effects of mycophenolate mofetil introduction in liver transplant patients: results from an observational, non-interventional, multicenter study (LOBSTER)
    Schlitt, Hans J.
    Jonas, Sven
    Ganten, Tom M.
    Grannas, Gerrit
    Moench, Christian
    Rauchfuss, Falk
    Obed, Aiman
    Tisone, Giuseppe
    Pinna, Antonio D.
    Gerunda, Giorgio E.
    Beckebaum, Susanne
    CLINICAL TRANSPLANTATION, 2013, 27 (03) : 368 - 378
  • [29] 5 years safety of fingolimod in real world: Results from PANGAEA, a non-interventional study of RRMS patients in Germany
    Ziemssen, T.
    Albrecht, H.
    Haas, J.
    Klotz, L.
    Lang, M.
    Lassek, C.
    Schmidt, S.
    Tackenberg, B.
    Cornelissen, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 197 - 197
  • [30] DEFERASIROX FOR THE TREATMENT OF TRANSFUSIONAL IRON OVERLOAD IN SICKLE CELL ANEMIA: A 1-YR PROSPECTIVE STUDY
    Cancado, R.
    Olivato, M. C. A.
    Bruniera, P.
    Chiattone, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 83 - 83